Preliminary dermatopharmacokinetic study of flurbiprofen-containing tape (LC1702) in healthy adult males
Phase 1
Active, not recruiting
- Conditions
- healthy adult males
- Registration Number
- JPRN-jRCT2031230393
- Lead Sponsor
- Takazawa Kenji
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Recruiting
- Sex
- Male
- Target Recruitment
- 8
Inclusion Criteria
(1) Age: 20 to 40 years old (at the time of obtaining consent)
(2) Persons whose BMI (Body Mass Index: weight (kg) / height (mm)2) is 18.5 kg/m2 or more and less than 25 kg/m2 (numbers are not rounded).
Exclusion Criteria
(1) Persons with hypersensitivity or idiosyncrasy to drugs, etc.
(2) Persons with a history of bronchial asthma.
(3) Persons with diseases of the gastrointestinal tract, heart, liver, kidneys, etc. that affect drug metabolism and excretion.
(4) Persons with have skin wounds at the administration site, and those who have skin symptoms such as eczema, contact dermatitis, psoriasis, seborrheic dermatitis, dyschromatosis, and excessive sunburn at the administration site.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Calculation of drug amount in the stratum corneum
- Secondary Outcome Measures
Name Time Method